Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.500
-0.004 (-0.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bolt Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 19 | 43 | 49 | 183 | - | - | |
Market Cap Growth | -37.18% | -13.15% | -73.20% | - | - | - | |
Enterprise Value | -16 | -56 | -99 | -5 | - | - | |
Last Close Price | 0.50 | 1.12 | 1.30 | 4.90 | - | - | |
PS Ratio | 1.95 | 5.40 | 8.55 | 145.00 | - | - | |
PB Ratio | 0.27 | 0.38 | 0.29 | 0.73 | - | - | |
P/TBV Ratio | 0.34 | 0.38 | 0.29 | 0.73 | - | - | |
Debt / Equity Ratio | 0.25 | 0.18 | 0.13 | 0.10 | 0.43 | 0.32 | |
Asset Turnover | 0.07 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | |
Quick Ratio | 3.00 | 5.06 | 7.31 | 8.73 | 2.03 | 4.06 | |
Current Ratio | 3.16 | 5.17 | 7.47 | 8.87 | 2.25 | 4.15 | |
Return on Equity (ROE) | -64.99% | -48.69% | -41.79% | -71.52% | -212.22% | -136.76% | |
Return on Assets (ROA) | -31.76% | -24.57% | -21.08% | -32.74% | -64.72% | -60.09% | |
Return on Capital (ROIC) | -37.78% | -29.12% | -24.09% | -37.30% | -78.52% | -70.63% | |
Earnings Yield | -340.11% | -162.73% | -179.94% | -53.96% | - | - | |
FCF Yield | -319.66% | -163.99% | -160.25% | -32.52% | - | - | |
Buyback Yield / Dilution | -1.02% | -1.21% | -12.54% | -1479.05% | -5.46% | -20.76% | |
Total Shareholder Return | -1.02% | -1.21% | -12.54% | -1479.05% | -5.46% | -20.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.